Julia Roick1, Helge Danker2, Andreas Dietz3, Kirsten Papsdorf4, Susanne Singer5. 1. Institute of Medical Sociology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 8, 06112, Halle (Saale), Germany. Julia.Roick@medizin.uni-halle.de. 2. Division of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Leipzig, Germany. 3. Department of Otolaryngology, University Medical Center Leipzig, Leipzig, Germany. 4. Department of Radiation-Oncology, University Medical Center Leipzig, Leipzig, Germany. 5. Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre of Johannes Gutenberg University Mainz, Mainz, Germany.
Abstract
PURPOSE: Patients with head and neck cancer experience multiple complaints during treatment which also affect quality of life. The present study assessed predictors of temporal changes in quality of life over a 6-month period among patients treated for head and neck cancer. METHODS: Patients completed questionnaires at the beginning (t1) and end (t2) of their hospital stay and 3 (t3) and 6 months (t4) thereafter. Quality of life was evaluated using EORTC QLQ-C30 and QLQ-H&N35. Descriptive statistics were computed across measurement points for different domains of quality of life; predictors were identified using general linear models. RESULTS: Eighty-three patients (mean age: 58, SD = 11, 20.5% female) participated. Quality of life decreased during treatment and slowly recovered thereafter. From t1 to t4, there were adverse changes that patients consider to be relevant in physical and role functioning, fatigue, dyspnea, insomnia, loss of appetite, financial difficulties, problems with senses and teeth, limited mouth opening, mouth dryness, social eating, coughing, and sticky saliva. Temporal changes in global quality of life between t1 and t2 were predicted by tumor stage (B = - 5.6, p = 0.04) and well-being (B = 0.8, p = 0.04); radiotherapy was a predictor of temporal changes in physical functioning (B = - 12.5, p = 0.03). CONCLUSIONS: Quality of life decreases during treatment, half a year after hospital stay there are still restrictions in some areas. A special focus should be given on head and neck cancer patient's quality of life in the aftercare.
PURPOSE:Patients with head and neck cancer experience multiple complaints during treatment which also affect quality of life. The present study assessed predictors of temporal changes in quality of life over a 6-month period among patients treated for head and neck cancer. METHODS:Patients completed questionnaires at the beginning (t1) and end (t2) of their hospital stay and 3 (t3) and 6 months (t4) thereafter. Quality of life was evaluated using EORTC QLQ-C30 and QLQ-H&N35. Descriptive statistics were computed across measurement points for different domains of quality of life; predictors were identified using general linear models. RESULTS: Eighty-three patients (mean age: 58, SD = 11, 20.5% female) participated. Quality of life decreased during treatment and slowly recovered thereafter. From t1 to t4, there were adverse changes that patients consider to be relevant in physical and role functioning, fatigue, dyspnea, insomnia, loss of appetite, financial difficulties, problems with senses and teeth, limited mouth opening, mouth dryness, social eating, coughing, and sticky saliva. Temporal changes in global quality of life between t1 and t2 were predicted by tumor stage (B = - 5.6, p = 0.04) and well-being (B = 0.8, p = 0.04); radiotherapy was a predictor of temporal changes in physical functioning (B = - 12.5, p = 0.03). CONCLUSIONS: Quality of life decreases during treatment, half a year after hospital stay there are still restrictions in some areas. A special focus should be given on head and neck cancerpatient's quality of life in the aftercare.
Entities:
Keywords:
Head and neck cancer; Longitudinal study; Predictors; Prospective study; Quality of life
Authors: Christiane Schultz; Maria Valéria Schmidt Goffi-Gomez; Patrícia Helena Pecora Liberman; Antonio Cássio de Assis Pellizzon; André Lopes Carvalho Journal: Arch Otolaryngol Head Neck Surg Date: 2010-11
Authors: S Tribius; M S Meyer; C Pflug; H Hanken; C-J Busch; A Krüll; C Petersen; C Bergelt Journal: Strahlenther Onkol Date: 2018-05-07 Impact factor: 3.621
Authors: E Hammerlid; K Bjordal; M Ahlner-Elmqvist; M Jannert; S Kaasa; M Sullivan; T Westin Journal: Otolaryngol Head Neck Surg Date: 1997-06 Impact factor: 3.497
Authors: C Paul van Wilgen; Pieter U Dijkstra; Berend F A M van der Laan; John T Plukker; Jan L N Roodenburg Journal: Head Neck Date: 2004-09 Impact factor: 3.147
Authors: François Meyer; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu; Isabelle Bairati Journal: J Clin Oncol Date: 2009-05-18 Impact factor: 44.544
Authors: Bernhard Holzner; Johannes M Giesinger; Jakob Pinggera; Stefan Zugal; Felix Schöpf; Anne S Oberguggenberger; Eva M Gamper; August Zabernigg; Barbara Weber; Gerhard Rumpold Journal: BMC Med Inform Decis Mak Date: 2012-11-09 Impact factor: 2.796
Authors: Rosanne C Schoonbeek; Julius de Vries; Linda Bras; Grigory Sidorenkov; Boudewijn E C Plaat; Max J H Witjes; Bernard F A M van der Laan; Johanna G M van den Hoek; Boukje A C van Dijk; Johannes A Langendijk; György B Halmos Journal: Eur J Cancer Care (Engl) Date: 2022-04-19 Impact factor: 2.328